EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction

Jun Wan iD, Feng Xu iD, Heping Zuo, Xin Jiang, Yulin Wang, Yang Jiang, Cai Chen, Chunlin Yin, Jinglin Cheng iD, He Li

Journal of Cardiovascular Pharmacology and Therapeutics · 2024

DOI: 10.1177/10742484241301191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, 2024. Verfasst von Jun Wan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Internal Medicine, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Ventricular Remodeling, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Ventricular Function, Left. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the effect of sodium-glucose cotransporter 2 inhibitors (SGLT2-I) on cardiac remodeling and prognosis in type 2 diabetes mellitus (T2DM) patients presenting with acute myocardial infarction (AMI).

Methods

In this single-center retrospective active-comparator study, consecutive diabetic AMI patients undergoing percutaneous coronary intervention (PCI) between 2021 and 2023 were enrolled. Patients were divided into SGLT2-I users and non-SGLT2-I users based on discharge medications. The primary endpoint was the left ventricular remodeling index (LVRI), defined as the relative change in LV end-diastolic volume after six months. The secondary outcomes included major adverse cardiovascular events (MACE), comprising all-cause mortality, hospitalization for heart failure, nonfatal MI, and nonfatal stroke.

Results

The study comprised 423 T2DM AMI patients(with or without ST-segment elevation), with 239 SGLT2-I users and 184 non-SGLT2-I users. At six months, LVRI was significantly lower in the SGLT2-I users compared to the non-SGLT2-I users (3.49 ± 19.71 vs 7.06 ± 15.15, P = .042). The non-SGLT2-I users exhibited a higher prevalence of positive LVR (LVRI > 0%) (64.67% vs 50.63%, P = .004) and pathological LVR (LVRI > 20%) (19.57% vs 12.13%, P = .036). Multivariate logistic regression indicated that SGLT2-I was associated with a reduced risk of LVR (OR 0.6; 95%CI 0.38-0.97; P = .035). During a mean follow-up of 25 ± 8 months, Kaplan-Meier analysis demonstrated a lower rate of MACE-free survival in the non-SGLT2-I users ( P = .005).

Conclusions

SGLT2-I protects against LVR and lowers the risk of adverse cardiovascular outcomes in T2DM AMI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular RemodelingSodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2Ventricular Function, LeftPercutaneous Coronary InterventionMyocardial InfarctionHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeTime FactorsRisk AssessmentRisk Factors

Stichwörter der Autor:innen

SGLT2-IT2DMacute myocardial infarctioncardiac remodeling

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Emergency Internal Medicine, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of Electrocardiographic Diagnosis, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of Emergency Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Jun Wan, Feng Xu, Jinglin Cheng

Zitieren

APA

Wan, J., Xu, F., Zuo, H., Jiang, X., Wang, Y., Jiang, Y., Chen, C., Yin, C., Cheng, J., & Li, H. (2024). Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction. Journal of Cardiovascular Pharmacology and Therapeutics. https://doi.org/10.1177/10742484241301191

Vancouver

Wan J, Xu F, Zuo H, Jiang X, Wang Y, Jiang Y, et al. Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction. Journal of Cardiovascular Pharmacology and Therapeutics. 2024. doi:10.1177/10742484241301191

BibTeX
@article{Wan2024,
  author = {Wan, Jun and Xu, Feng and Zuo, Heping and Jiang, Xin and Wang, Yulin and Jiang, Yang and Chen, Cai and Yin, Chunlin and Cheng, Jinglin and Li, He},
  title = {Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction},
  journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1177/10742484241301191}
}
Kostenlos starten →